
Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts
Dive Brief: Biotech executives and venture capital investors are banding together to press Congress to act on Food and Drug Administration layoffs they say are already impacting drug development. In a letter to Bill Cassidy, R-La., the head of the Senate’s …